{"id":"https://openalex.org/W4410463539","doi":"https://doi.org/10.1016/j.esmoop.2025.104630","title":"76P Real-world study of ESR1 mutation testing by liquid biopsy using digital PCR or NGS to guide elacestrant use in metastatic breast cancer patients","display_name":"76P Real-world study of ESR1 mutation testing by liquid biopsy using digital PCR or NGS to guide elacestrant use in metastatic breast cancer patients","alternate_titles":[],"publication_year":2025,"publication_date":"2025-05-01","ids":{"openalex":"https://openalex.org/W4410463539","doi":"https://doi.org/10.1016/j.esmoop.2025.104630"},"language":"en","primary_location":{"id":"doi:10.1016/j.esmoop.2025.104630","doi":"https://doi.org/10.1016/j.esmoop.2025.104630","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.esmoop.2025.104630","pdf_url":"https://www.esmoopen.com/action/showPdf?pii=S2059702925004995","source":{"id":"https://openalex.org/S4210217024","display_name":"ESMO Open","issn_l":"2059-7029","issn":["2059-7029"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","oarl","poland-40","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"ESMO Open","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W4410463539"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.esmoopen.com/action/showPdf?pii=S2059702925004995","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5012974257","display_name":"Federico Rojo","orcid":"https://orcid.org/0000-0001-9989-0290","observed_orcids":["https://orcid.org/0000-0001-9989-0290"]},"institutions":[{"id":"https://openalex.org/I4210129357","display_name":"Hospital Universitario Fundaci\u00f3n Jim\u00e9nez D\u00edaz","ror":"https://ror.org/049nvyb15","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210129357"]},{"id":"https://openalex.org/I4210158561","display_name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer","ror":"https://ror.org/04hya7017","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210158561"]},{"id":"https://openalex.org/I4210163263","display_name":"GEICAM \u2013 Spanish Breast Cancer Group","ror":"https://ror.org/05ygm7711","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I4210163263"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"F.G.T. Rojo","raw_affiliation_strings":["Pathology Department, Hospital Universitario Fundacion Jimenez Diaz. CIBERONC-ISCIII. GEICAM Spanish Breast Cancer Group, Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pathology Department, Hospital Universitario Fundacion Jimenez Diaz. CIBERONC-ISCIII. GEICAM Spanish Breast Cancer Group, Madrid, Spain","institution_ids":["https://openalex.org/I4210129357","https://openalex.org/I4210158561","https://openalex.org/I4210163263"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059154500","display_name":"V. Guarneri","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I138689650","display_name":"University of Padua","ror":"https://ror.org/00240q980","country_code":"IT","type":"education","lineage":["https://openalex.org/I138689650"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"V. Guarneri","raw_affiliation_strings":["Department of Surgery, Oncology and Gastroenterology Dept., University of Padua, Padua, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Surgery, Oncology and Gastroenterology Dept., University of Padua, Padua, Italy","institution_ids":["https://openalex.org/I138689650"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073541319","display_name":"Andrea Boscolo Bragadin","orcid":"https://orcid.org/0000-0001-9614-0814","observed_orcids":["https://orcid.org/0000-0001-9614-0814"]},"institutions":[{"id":"https://openalex.org/I4210109345","display_name":"Istituto Oncologico Veneto","ror":"https://ror.org/01xcjmy57","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210109345","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"A. Boscolo Bragadin","raw_affiliation_strings":["Surgery, Oncology and Gastroenterology, IOV - Istituto Oncologico Veneto IRCCS, Padua, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Surgery, Oncology and Gastroenterology, IOV - Istituto Oncologico Veneto IRCCS, Padua, Italy","institution_ids":["https://openalex.org/I4210109345"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026589555","display_name":"Stefano Indraccolo","orcid":"https://orcid.org/0000-0002-4810-7136","observed_orcids":["https://orcid.org/0000-0002-4810-7136"]},"institutions":[{"id":"https://openalex.org/I138689650","display_name":"University of Padua","ror":"https://ror.org/00240q980","country_code":"IT","type":"education","lineage":["https://openalex.org/I138689650"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"S. Indraccolo","raw_affiliation_strings":["Department of Surgery, Oncology and Gastroenterology Dept., University of Padua, Padua, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Surgery, Oncology and Gastroenterology Dept., University of Padua, Padua, Italy","institution_ids":["https://openalex.org/I138689650"]}]},{"author_position":"middle","author":{"id":null,"display_name":"E. Guerini Rocco","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I6141010","display_name":"European Institute of Oncology","ror":"https://ror.org/02vr0ne26","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I6141010"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"E. Guerini Rocco","raw_affiliation_strings":["Division of Pathology, European Institute of Oncology IRCCS, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Pathology, European Institute of Oncology IRCCS, Milan, Italy","institution_ids":["https://openalex.org/I6141010"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109278742","display_name":"Nicola Fusco","orcid":"https://orcid.org/0000-0002-9101-9131","observed_orcids":["https://orcid.org/0000-0002-9101-9131"]},"institutions":[{"id":"https://openalex.org/I6141010","display_name":"European Institute of Oncology","ror":"https://ror.org/02vr0ne26","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I6141010"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"N. Fusco","raw_affiliation_strings":["Division of Pathology, IEO - Istituto Europeo di Oncologia IRCCS, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Pathology, IEO - Istituto Europeo di Oncologia IRCCS, Milan, Italy","institution_ids":["https://openalex.org/I6141010"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090505952","display_name":"Sandra Zazo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210129357","display_name":"Hospital Universitario Fundaci\u00f3n Jim\u00e9nez D\u00edaz","ror":"https://ror.org/049nvyb15","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210129357"]},{"id":"https://openalex.org/I4210158561","display_name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer","ror":"https://ror.org/04hya7017","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210158561"]},{"id":"https://openalex.org/I4210163263","display_name":"GEICAM \u2013 Spanish Breast Cancer Group","ror":"https://ror.org/05ygm7711","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I4210163263"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"S. Zazo","raw_affiliation_strings":["Pathology Department, Hospital Universitario Fundacion Jimenez Diaz. CIBERONC-ISCIII. GEICAM Spanish Breast Cancer Group, Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pathology Department, Hospital Universitario Fundacion Jimenez Diaz. CIBERONC-ISCIII. GEICAM Spanish Breast Cancer Group, Madrid, Spain","institution_ids":["https://openalex.org/I4210129357","https://openalex.org/I4210158561","https://openalex.org/I4210163263"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022693395","display_name":"Iv\u00e1n Prieto\u2010Pot\u00edn","orcid":"https://orcid.org/0000-0001-9054-4359","observed_orcids":["https://orcid.org/0000-0001-9054-4359"]},"institutions":[{"id":"https://openalex.org/I4210129357","display_name":"Hospital Universitario Fundaci\u00f3n Jim\u00e9nez D\u00edaz","ror":"https://ror.org/049nvyb15","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210129357"]},{"id":"https://openalex.org/I4210158561","display_name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer","ror":"https://ror.org/04hya7017","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210158561"]},{"id":"https://openalex.org/I4210163263","display_name":"GEICAM \u2013 Spanish Breast Cancer Group","ror":"https://ror.org/05ygm7711","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I4210163263"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"I. Prieto-Potin","raw_affiliation_strings":["Pathology Department, Hospital Universitario Fundacion Jimenez Diaz. CIBERONC-ISCIII. GEICAM Spanish Breast Cancer Group, Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pathology Department, Hospital Universitario Fundacion Jimenez Diaz. CIBERONC-ISCIII. GEICAM Spanish Breast Cancer Group, Madrid, Spain","institution_ids":["https://openalex.org/I4210129357","https://openalex.org/I4210158561","https://openalex.org/I4210163263"]}]},{"author_position":"middle","author":{"id":null,"display_name":"R. Adorisio","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I6141010","display_name":"European Institute of Oncology","ror":"https://ror.org/02vr0ne26","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I6141010"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"R. Adorisio","raw_affiliation_strings":["Division of Pathology, European Institute of Oncology IRCCS, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Pathology, European Institute of Oncology IRCCS, Milan, Italy","institution_ids":["https://openalex.org/I6141010"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071102498","display_name":"Francesco Pepe","orcid":"https://orcid.org/0000-0002-2803-9586","observed_orcids":["https://orcid.org/0000-0002-2803-9586","https://orcid.org/0009-0007-5980-8345"]},"institutions":[{"id":"https://openalex.org/I4210117450","display_name":"Federico II University Hospital","ror":"https://ror.org/02jr6tp70","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210117450","https://openalex.org/I71267560"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"F. Pepe","raw_affiliation_strings":["Pathology, Azienda Ospedaliera Universitaria Federico II, Naples, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pathology, Azienda Ospedaliera Universitaria Federico II, Naples, Italy","institution_ids":["https://openalex.org/I4210117450"]}]},{"author_position":"middle","author":{"id":null,"display_name":"J. Herzog","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210108499","display_name":"Menarini Group (Italy)","ror":"https://ror.org/02h1wg091","country_code":"IT","type":"company","lineage":["https://openalex.org/I4210108499"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"J. Herzog","raw_affiliation_strings":["Diagnostic & Operations, Menarini Ricerche S.p.A, Pomezia, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Diagnostic & Operations, Menarini Ricerche S.p.A, Pomezia, Italy","institution_ids":["https://openalex.org/I4210108499"]}]},{"author_position":"middle","author":{"id":null,"display_name":"M. Orellana","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M. Orellana","raw_affiliation_strings":["Diagnostic & Operations, Laboratorios Menarini S.A., Badalona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Diagnostic & Operations, Laboratorios Menarini S.A., Badalona, Spain","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5017669867","display_name":"Umberto Malapelle","orcid":"https://orcid.org/0000-0003-3211-9957","observed_orcids":["https://orcid.org/0000-0003-3211-9957"]},"institutions":[{"id":"https://openalex.org/I71267560","display_name":"University of Naples Federico II","ror":"https://ror.org/05290cv24","country_code":"IT","type":"education","lineage":["https://openalex.org/I71267560"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"U. Malapelle","raw_affiliation_strings":["Public Health Dept., Universit\u00e0 degli Studi di Napoli Federico II - Scuola di Medicina e Chirurgia, Naples, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Public Health Dept., Universit\u00e0 degli Studi di Napoli Federico II - Scuola di Medicina e Chirurgia, Naples, Italy","institution_ids":["https://openalex.org/I71267560"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":9,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3910,"currency":"USD","value_usd":3910},"apc_paid":{"value":3910,"currency":"USD","value_usd":3910},"fwci":0.737,"has_fulltext":true,"cited_by_count":2,"citation_normalized_percentile":{"value":0.66685762,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":95},"biblio":{"volume":"10","issue":null,"first_page":"104630","last_page":"104630"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.9624000191688538,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.9624000191688538,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11287","display_name":"Cancer Genomics and Diagnostics","score":0.01889999955892563,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.008100000210106373,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/elacestrant","display_name":"elacestrant","score":0.9330000281333923},{"id":"https://openalex.org/keywords/metastatic-breast-cancer","display_name":"metastatic breast cancer","score":0.9430000185966492},{"id":"https://openalex.org/keywords/er-positive-her2-negative-breast-cancer","display_name":"ER-positive HER2-negative breast cancer","score":0.8539999723434448},{"id":"https://openalex.org/keywords/liquid-biopsy","display_name":"liquid biopsy","score":0.9449999928474426},{"id":"https://openalex.org/keywords/digital-pcr","display_name":"digital PCR","score":0.9800000190734863},{"id":"https://openalex.org/keywords/next-generation-sequencing","display_name":"next-generation sequencing","score":0.8830000162124634},{"id":"https://openalex.org/keywords/endocrine-therapy","display_name":"endocrine therapy","score":0.6290000081062317},{"id":"https://openalex.org/keywords/cdk4-6-inhibitors","display_name":"CDK4/6 inhibitors","score":0.972000002861023},{"id":"https://openalex.org/keywords/early-access-program","display_name":"early access program","score":0.7329999804496765},{"id":"https://openalex.org/keywords/real-world-evidence","display_name":"real-world evidence","score":0.6200000047683716}],"concepts":[{"id":"https://openalex.org/C48126324","wikidata":"https://www.wikidata.org/wiki/Q5276136","display_name":"Digital polymerase chain reaction","level":4,"score":0.6854469180107117},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.6118311882019043},{"id":"https://openalex.org/C2779529041","wikidata":"https://www.wikidata.org/wiki/Q22349364","display_name":"Liquid biopsy","level":3,"score":0.6085297465324402},{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.5305699706077576},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5070674419403076},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4533767104148865},{"id":"https://openalex.org/C2775934546","wikidata":"https://www.wikidata.org/wiki/Q179991","display_name":"Biopsy","level":2,"score":0.4447823762893677},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.39481034874916077},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.3516817092895508},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.33640366792678833},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3355207145214081},{"id":"https://openalex.org/C49105822","wikidata":"https://www.wikidata.org/wiki/Q176996","display_name":"Polymerase chain reaction","level":3,"score":0.26229989528656006},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.25587570667266846},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.1573111116886139},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.1326567828655243}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/j.esmoop.2025.104630","doi":"https://doi.org/10.1016/j.esmoop.2025.104630","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.esmoop.2025.104630","pdf_url":"https://www.esmoopen.com/action/showPdf?pii=S2059702925004995","source":{"id":"https://openalex.org/S4210217024","display_name":"ESMO Open","issn_l":"2059-7029","issn":["2059-7029"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","oarl","poland-40","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"ESMO Open","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1016/j.esmoop.2025.104630","doi":"https://doi.org/10.1016/j.esmoop.2025.104630","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.esmoop.2025.104630","pdf_url":"https://www.esmoopen.com/action/showPdf?pii=S2059702925004995","source":{"id":"https://openalex.org/S4210217024","display_name":"ESMO Open","issn_l":"2059-7029","issn":["2059-7029"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","oarl","poland-40","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"ESMO Open","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307770","display_name":"AstraZeneca","ror":"https://ror.org/04r9x1a08"},{"id":"https://openalex.org/F4320307773","display_name":"GlaxoSmithKline","ror":"https://ror.org/01xsqw823"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4410463539.pdf","grobid_xml":"https://content.openalex.org/works/W4410463539.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4405107382","https://openalex.org/W7129211175","https://openalex.org/W7162034791","https://openalex.org/W4396591679","https://openalex.org/W4416239499","https://openalex.org/W4411289926","https://openalex.org/W4402172089","https://openalex.org/W4411288808","https://openalex.org/W4416008359","https://openalex.org/W7129303380"],"abstract_inverted_index":{"The":[0,65],"EMERALD":[1],"trial":[2],"(NCT03778931)":[3],"showed":[4],"improved":[5],"PFS":[6],"with":[7,19],"elacestrant":[8,62,68],"vs":[9],"standard":[10],"of":[11,67],"care":[12],"(SOC)":[13],"endocrine":[14],"therapy":[15],"(ET)":[16],"in":[17,55],"patients":[18],"ER+/HER2\u2212":[20],"mBC":[21],"and":[22,44],"tumors":[23],"harboring":[24],"ESR1-mut":[25],"after":[26],"prior":[27],"ET+CDK4/6i;":[28],"HR=0.55;":[29],"95%":[30],"CI,":[31],"0.39-0.77;":[32],"P=0.0005":[33],"(Bidard":[34],"2022),":[35],"leading":[36],"to":[37,57,61,78],"its":[38],"approval":[39],"by":[40],"FDA,":[41],"EMA,":[42],"MHRA":[43],"other":[45],"regulatory":[46],"agencies.":[47],"An":[48],"Early":[49],"Access":[50],"Program":[51],"(EAP)":[52],"was":[53],"initiated":[54],"Europe":[56],"enable":[58],"patient":[59],"access":[60],"before":[63],"reimbursement.":[64],"availability":[66],"emphasizes":[69],"the":[70],"need":[71],"for":[72],"real-time":[73],"mutation":[74],"detection":[75],"upon":[76],"progression":[77],"guide":[79],"treatments.":[80]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4410463539","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1}],"updated_date":"2026-11-14T11:04:58.165337","created_date":"2025-05-18T00:00:00"}
